Showing results (401-410 of 649) with videos related to
Sort By:
Pageof 65
Hemasphere|June 5, 2024
Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAndreas J M Ferreri, Gerald Illerhaus, Jeanette K Doorduijn, et al.Hemasphere|July 8, 2024
Biological relapse in multiple myeloma: Outcome and treatment strategies in a Spanish real-world settingAdrián Alegre, Mercedes Gironella, Fernando Escalante, et al.Hemasphere|May 17, 2024
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortiumCristina A Tentori, Lin P Zhao, Benedetta Tinterri, et al.Hemasphere|October 6, 2023
Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti-CD19 CAR T-cell Treated PatientsVictoria Panagiota, Johanna Franziska Kerschbaum, Olaf Penack, et al.Hemasphere|September 21, 2023
High-throughput Proteomics Identifies THEMIS2 as Independent Biomarker of Treatment-free Survival in Untreated CLLPaul J Hengeveld, P Martijn Kolijn, Jeroen A A Demmers, et al.Hemasphere|July 20, 2023
Context-dependent T-cell Receptor Gene Repertoire Profiles in Proliferations of T Large Granular LymphocytesJorn L J C Assmann, Elisavet Vlachonikola, Pieter M Kolijn, et al.Hemasphere|July 14, 2023
Histone Variants and Their Chaperones in Hematological MalignanciesEcem Kirkiz, Oliver Meers, Florian Grebien, et al.Hemasphere|July 14, 2023
Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product UseVeit Bücklein, Ariel Perez, Kai Rejeski, et al.Hemasphere|June 30, 2023
Biomolecular Condensates in Myeloid Leukemia: What Do They Tell Us?Zivojin Jevtic, Melanie Allram, Florian Grebien, et al.Hemasphere|July 5, 2023
Donor Lymphocyte Infusion and Molecular Monitoring for Relapsed Myelofibrosis After Hematopoietic Cell TransplantationNico Gagelmann, Christine Wolschke, Anita Badbaran, et al.Pageof 65